BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25333507)

  • 1. Necrolytic migratory erythema associated with alteration from predominantly gastrin-secreting to predominantly glucagon-secreting pancreatic neuroendocrine tumor.
    Kido-Nakahara M; Nakahara T; Miki M; Igarashi H; Ito T; Furue M
    Eur J Dermatol; 2014; 24(6):702-3. PubMed ID: 25333507
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed diagnosis of glucagonoma syndrome: a case report.
    Huo J; Liu P; Chen X; Wu J; An J; Ren J
    Int J Dermatol; 2016 Nov; 55(11):1272-1274. PubMed ID: 26679842
    [No Abstract]   [Full Text] [Related]  

  • 3. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
    Tremblay C; Marcil I
    J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic glucagonoma with pancreatic calcification.
    Gupta RA; Udwadia FE; Agrawal P; Doctor N
    Pancreatology; 2013; 13(3):327-9. PubMed ID: 23719610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagonoma syndrome associated with necrolytic migratory erythema.
    Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
    Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
    Technau K; Renkl A; Norgauer J; Ziemer M
    Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normoglycemic glucagonoma syndrome associated with necrolytic migratory erythema.
    Feldmann R; Wahl S; Steiner A
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):e306-e307. PubMed ID: 29419911
    [No Abstract]   [Full Text] [Related]  

  • 8. Necrolytic migratory erythema: a common cutaneous clue of uncommon syndromes.
    Stavropoulos PG; Papafragkaki DK; Avgerinou G; Papafragkakis H; Katsavou A; Katsambas AD
    Cutis; 2013 Nov; 92(5):E1-4. PubMed ID: 24343217
    [No Abstract]   [Full Text] [Related]  

  • 9. Necrolytic migratory erythema associated with glucagonoma treated successfully with cyclosporine.
    Jiménez-Gallo D; Ossorio-García L; de la Varga-Martínez R; Arjona-Aguilera C; Linares-Barrios M
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508546
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucagonoma syndrome with atypical necrolytic migratory erythema.
    He S; Zeng W; Geng S; Jia J
    Indian J Dermatol Venereol Leprol; 2021; 87(1):49-53. PubMed ID: 31368453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.
    Wu SL; Bai JG; Xu J; Ma QY; Wu Z
    World J Surg Oncol; 2014 Jul; 12():220. PubMed ID: 25029913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Necrolytic migratory erythema].
    Dandrifosse JF; Dandrifosse AC; Piérard G; Scheen AJ; Dandrifosse G
    Rev Med Liege; 1998 Dec; 53(12):778-83. PubMed ID: 9927878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Necrolytic migratory erythema revealing glucagonoma syndrome].
    Maouni S; Elanzi W; Sqalli A; Elmeknassi I; Meziane M; Benzekri L; Hassam B; Senouci K
    Ann Dermatol Venereol; 2019 May; 146(5):419-421. PubMed ID: 30910336
    [No Abstract]   [Full Text] [Related]  

  • 14. Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma.
    Saavedra C; Lamarca A; Hubner RA
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is your diagnosis? Necrolytic migratory erythema associated with a glucagonoma.
    Chaw L; Krop TM; Hood AF
    Cutis; 2008 Jan; 81(1):25, 30-2. PubMed ID: 18306843
    [No Abstract]   [Full Text] [Related]  

  • 16. Necrolytic migratory erythema associated with hyperglucagonemia and neuroendocrine hepatic tumors.
    Marko PB; Miljković J; Zemljic TG
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Dec; 14(4):161-4, 166. PubMed ID: 16435046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagonoma with necrolytic migratory erythema exhibiting responsiveness to subcutaneous octreotide injections.
    Lo CH; Ho CL; Shih YL
    QJM; 2014 Feb; 107(2):157-8. PubMed ID: 23389434
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuropsychiatric symptoms, skin disease, and weight loss: necrolytic migratory erythema and a glucagonoma.
    Boujan N; Géraud C
    Lancet; 2020 Mar; 395(10228):985. PubMed ID: 32199485
    [No Abstract]   [Full Text] [Related]  

  • 19. Migratory necrolytic erythema and glucagonoma.
    Echenique-Elizondo M; Elorza JL; De Delas JS
    Surgery; 2003 Apr; 133(4):449-50. PubMed ID: 12717367
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucagonoma-Associated Necrolytic Migratory Erythema: The Broad Spectrum of the Clinical and Histopathological Findings and Clues to the Diagnosis.
    Toberer F; Hartschuh W; Wiedemeyer K
    Am J Dermatopathol; 2019 Mar; 41(3):e29-e32. PubMed ID: 30124507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.